Loading the security page…
A security analysis is not yet prepared for this market.
Based on the last 12 months of reports, through 30 June 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Rhythm Pharmaceuticals, Inc. (RYTM) is a company in the Health care sector; its shares trade on Nasdaq.
The price of Rhythm Pharmaceuticals, Inc. (RYTM) on November 13, 2026 is 115.02 $, +4.70 % on the day. Over 52 weeks the stock traded between 74.50 $ and 122.20 $; the price now sits 85 % of the way up that range. Over the past year the price changed by +17.46 %. Market capitalization is 7.92 billion $, rank 29 among 382 stocks of the same industry with a known capitalization.
Rhythm Pharmaceuticals, Inc. trades on Nasdaq under the ticker RYTM. The company belongs to the Health care sector. The trading history on this page starts on 9 October 2017.
Over the past 52 weeks RYTM has traded between 74.50 $ and 122.20 $. As of 13 November 2026 the price stood 84.95% of the way from the 52-week low to the high.
Over one year RYTM shares rose 19.95%; over six months they rose 27.07%. Volatility over 90 days is 58.18%. Dividends are not included: this is price change only, as of 13 November 2026.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to sales is 33.0, above the sector median of 3.7. Price to book is 76.9, above the sector median of 2.3. Calculated from reports for the period ending 30 June 2026.
Rhythm Pharmaceuticals, Inc. reported revenue of 240M $ and a net loss of 205M $ over the last four quarters. Net margin is −85.59%. Revenue changed by +53.51% year over year. Earnings per share are −$3.12. Market capitalisation is 7.9B $.
RYTM has a return on equity of −199.40%, below the sector median of −40.58%. Return on assets is −46.96%, below the sector median of −30.08%. Operating margin is −83.62%, below the sector median of −20.96%.